COVID-19 Update - This is to inform you that the Government of India has announced a complete lockdown in India 22nd March 2020 to 3rd May 2020. As a result, our offices will now be closed till 3rd May 2020 and all our employees will be working from home. Office telephones will not be answered, and therefore you are requested to direct all your queries related to manuscript submission, review process, publication etc. at below mentioned details. editor@innovativepublication.com, rakesh.its@gmail.com, Mob. 8826373757, 8826859373, 9910947804


Print ISSN:-2394-2118

Online ISSN:-2394-2126

CODEN : IJCAGX

Current Issue

Year 2020

Volume: 7 , Issue: 1

Article Access statistics

Viewed: 640

Emailed: 0

PDF Downloaded: 164

Indian Journal of Clinical Anatomy and Physiology


Improvement in lipid profile of the patients with saxagliptin as add on therapy in patients of uncontrolled type 2 DM who were on metformin alone


Full Text PDF Share on Facebook Share on Twitter


Author Details : Akshay C. Dahiwele, Dinesh Kansal, Dheeraj Kapoor, Praveen Sharma

Volume : 2, Issue : 4, Year : 2017

Article Page : 115-117


Suggest article by email


Abstract

Introduction: Diabetes is characterized by chronic hyperglycemia and deranged carbohydrate, lipid and protein metabolism. This study shows an improvement in lipid profile (TC, TG, LDL and HDL) with saxagliptin in patients of uncontrolled type 2 diabetes mellitus (T2DM) who were previously on metformin monotherapy.
Materials and Method: A total of 30 patients with uncontrolled diabetes were enrolled, who were on metformin 1500 mg daily. Patients were given metformin 500 mg twice a day and saxagliptin 2.5 mg once a day. Patients were followed up at 1st, 3rd and 6th month and lipid profile (TC, TG, LDL and HDL) was estimated.
Results: The mean age ± SD in males and females was 61.42yrs ± 6.99 and 55.93yrs ± 5.74 respectively. The mean change in value from baseline at 24 weeks was TC= 9.66%, TG= 9.40%, LDL= 14.87%, HDL= 5.63%. A highly significant difference was seen at 0 v/s 1, 0 v/s3 and 0 v/s 6 months in lipid profile values.
Conclusion: Saxagliptin has shown an improvement in lipid profile (TC, TG, LDL, HDL) during 6 months of treatment duration in patients of T2DM.

Keywords: Saxagliptin, Uncontrolled Type 2DM, Metformin, Lipid Profile

 

How to cite : Dahiwele A C, Kansal D, Kapoor D, Sharma P, Improvement in lipid profile of the patients with saxagliptin as add on therapy in patients of uncontrolled type 2 DM who were on metformin alone. Indian J Clin Anat Physiol 2017;2(4):115-117

Copyright © 2017 by author(s) and Indian J Clin Anat Physiol. This is an Open Access article distributed under the terms of the Creative Commons Attribution License (CC BY 4.0) (creativecommons.org)